Nutrabolt has selected JPMorgan, Goldman Sachs and Bank of America to lead a potential U.S. IPO that could raise as much as $1 billion.
The Austin, Texas-based company has not publicly confirmed its IPO plans, while the banks declined to comment, according to Reuters.
Founded in 2002, Nutrabolt develops and markets energy drinks, protein powders, recovery drink mixes and sports nutrition products under brands including C4, XTEND and Cellucor. The company has also expanded into broader wellness categories through its investment in Bloom, initially acquiring a 20 percent stake in 2024 before increasing its ownership in 2025.